Viewing Study NCT04384367


Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-02-21 @ 6:45 PM
Study NCT ID: NCT04384367
Status: COMPLETED
Last Update Posted: 2025-02-14
First Post: 2020-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine
Sponsor: Eurofarma Laboratorios S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module